Mal-Dap(Boc)-Val-Cit-PAB-PNP

Chemical name: N-alpha-Maleimido-N-beta-t-butyloxycarbonyl-L-2,3-diaminopropionyl-valyl-citrullyl-(4-aminobenzyl)-(4-nitrophenyl)-carbonate // Synonyms: Mal-Dap(Boc)-Val-Cit-PAB-pNC, tert-butyl(S)-2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-((S)-3-methyl-1-((S)-1-(4-(((4-nitrophenoxy)carbonyloxy)methyl)phenylamino)-1-oxo-5-ureidopentan-2-ylamino)-1-o xobutan-2-ylamino)-3-oxopropylcarbamate

  • Product code:ADC1090
  • CAS No.:2281797-57-5
  • Formula:C37H46N8O13
  • Storage temperature:-20°C
  • Molecular weight:810.81 g/mol

from $312.50

Grouped product items
Qty Packing unit Price SKU Availability
25 mg
$312.50
ADC1090.0025
<10 business days
100 mg
$937.50
ADC1090.0100
<10 business days
250 mg
$1,875.00
ADC1090.0250
<10 business days
500 mg
$3,437.50
ADC1090.0500
Please inquire
description

Linker for Antibody-Drug-Conjugation (ADC). The Val-Cit will specifically be cleaved by catepsin B. As this enzyme is only present in the lysosome the ACD payload will be release in the cell, only. MAL-Dap(Boc) building blocks are ideal tools for persistent conjugation with thiol groups: After removal of the Boc protecting group and conjugation with the mercaptane function, the free methylamino side chain will open the maleimide ring under aqueous conditions. While the conjugation reaction between thiol and cyclic maleimide is reversible, it turns completely stable in the open ring structure. This becomes particularly important in the formation of conjugates with high value components.

Please note the patent WO2013173337 for use of this compound in commercial applications, particular for antibody-drug conjugates.


references

Laurent Ducry (ed.), Antibody-Drug Conjugates, Methods in Molecular Biology, vol. 1045, DOI 10.1007/978-1-62703-541-5_5, # Springer Science+Business Media, LLC 2013.

Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates; R.P. Lyon, J.R. Setter, T.D. Bovee, S.O. Doronia, J.H. Hunter, M.E. Anderson, C.L. Balasubramanian, S.M. Duniho, C.I. Leiske, F. Li, P.D. Senter; Nature Biotechnology 2014; 32(10): 1059-1062. DOI:10.1038/nbt.2968.

WO2013173337


* Disclaimer
We refer to our general terms and conditions.
All information contained in our webshop is compiled to the best of our knowledge.
Prices and product availability are subject to change and require reconfirmation. Please contact us for further information.

Do you need further information about this product?

get in contact

Quick contact

Please send me more information about

We found other products you might like!